RankAlpha logo
Back to Rankings

INO

InovioF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
INO vs peer average
20/100
INO vs. peer average (F vs. C)
Grade spread
A 1 · B 3 · C 1 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IMDX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $92.61M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIMDXInsight Molecular Diagnostics
INO
Inovio
IMDX
Insight Molecular Diagnostics
Grade
F
B
Momentum
40
7
Value
41
41
Sentiment
-
83
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs IMDX

INO / IMDX
Grade Position
Below peers
INO vs. peer average (F vs. C)
20/100
Momentum
40
INO
Value
41
INO
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs INO
1
IMDX
Insight Molecular Diagnostics Inc Common
B
80/100
+3
2
COYA
Coya Therapeutics Inc Common
F
20/100
Even
3
ICCC
ImmuCell Corp Common
C
60/100
+2
4
PLYX
Polaryx Therapeutics Inc Common
B
80/100
+3
5
NTHI
NeOnc Technologies Holdings Inc Common
F
20/100
Even
IMDX is the first peer returned for this comparison set.